Richard Chin, President and CEO, 10% Owner at Kindred Biosciences, Inc. (KIN), sold 2,400 shares at $10.00 ($24K) on 2018-05-18, disclosed to the SEC on 2018-05-18.
Scheduled sale ($24k) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KIN | SELL | 2021-06-17 | $367K | — | Filing → |
| KIN | SELL | 2019-01-04 | $423K | — | Filing → |
| KIN | SELL | 2018-12-04 | $531K | — | Filing → |